Alan Weintraub, MD
Gastroenterology · Tampa, FLNPI 1780609065
Payments from drug & device makers
Across 846 payments — averaging $5545.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$1.2M
- Janssen Research & Development, LLC$1.1M
- Sanofi US Services Inc.$969K
- AbbVie$662K
- Takeda Pharmaceuticals U.S.A., Inc.$520K
- Eli Lilly$245K
- plus $1K from 22 others
Across 2 payments — averaging $1427.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$3K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer(2 entities) | 300 | $1,198,692 |
| Janssen Research & Development, LLC | 231 | $1,094,605 |
| Sanofi US Services Inc. | 24 | $968,989 |
| AbbVie | 149 | $662,004 |
| Takeda Pharmaceuticals U.S.A., Inc. | 80 | $520,337 |
| Eli Lilly | 6 | $245,291 |
| Johnson & Johnson(2 entities) | 13 | $343 |
| Novo Nordisk | 14 | $293 |
| Janssen Scientific Affairs, LLC | 1 | $98 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $62 |
| Amgen | 4 | $62 |
| Celltrion USA Inc. | 2 | $45 |
| Abbott | 2 | $39 |
| Bristol Myers Squibb | 2 | $29 |
| Gilead | 2 | $29 |
| Aimmune Therapeutics, Inc. | 1 | $26 |
| Lilly USA, LLC | 1 | $22 |
| Vertos Medical, Inc. | 1 | $22 |
| Bayer | 1 | $20 |
| GSK | 1 | $20 |
| Merck | 1 | $19 |
| Amarin Pharma, Inc. | 1 | $18 |
| Lucid Diagnostics Inc. | 1 | $16 |
| Cleerly, Inc. | 1 | $14 |
| Intercept Pharmaceuticals, Inc. | 1 | $13 |
| Paratek Pharmaceuticals, Inc. | 1 | $13 |
| Biohaven Pharmaceuticals, Inc. | 1 | $13 |
| Evoke Pharma, Inc. | 1 | $12 |
How this compares
$4,691,147 in reported general payments places this provider in the 95th percentile of 1,388 gastroenterology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Tampa
- Angel RosarioTampa$1.4M
- Howard SchwartzTavernier$38.8M
- Guy NeffSarasota$17.6M
- Syed LateefClermont$6.4M
- Jeffrey SchneiderCoral Springs$6M
- Zaid RanaMiami$5.4M
- David NelsonGainesville$5.2M
- Curtis FreedlandNew Port Richey$4.5M
- Paul HellsternCrystal River$4.5M
- Henry LevineOrlando$3.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.